Featured Research

from universities, journals, and other organizations

Growth Hormone May Shorten Life Span, Study Finds

Date:
October 20, 2000
Source:
Ohio University
Summary:
Growth hormone often is prescribed to counteract such common effects of aging as loss of muscle tone and increase in body fat. But new animal studies of the natural hormone suggest that while it may improve quality of life, it may actually shorten the life span.

ATHENS, Ohio – Growth hormone often is prescribed to counteract such common effects of aging as loss of muscle tone and increase in body fat. But new animal studies of the natural hormone suggest that while it may improve quality of life, it may actually shorten the life span.

Related Articles


Researchers at Ohio University's Edison Biotechnology Institute found that mice engineered without the receptor for growth hormone lived almost one year longer than normal mice. The study, published in a recent issue of the journal Endocrinology, is the first to isolate growth hormone and analyze its impact on longevity.

Scientists say the findings have important implications for physicians who prescribe growth hormone replacement therapy for elderly patients and say doctors should use caution with these remedies until more studies are done.

"You may be improving quality of life, but you may be shortening the quantity of life," said Karen Coschigano, a scientist at the institute (EBI) and lead author of the recent study.

The project is one of many conducted at EBI to determine growth hormone's role in human health and illness, including acromegaly, diabetic kidney and eye diseases and breast cancer. To investigate its impact on aging, researchers studied three groups of mice: mice with normal or nearly normal levels of the growth hormone receptor, as well as mice with no growth hormone receptor. Mice in the last group were less than half the size of the other mice but lived almost one year longer than the other animals in the study. The normal life span for the mice used in the study was about two years, Coschigano said. Studies elsewhere have shown a similar increase in life span for mice with impaired pituitary function – which includes a lack of growth hormone activity.

Though the study suggests that disruption of the signal that activates growth hormone may prolong life, she added, the researchers have yet to determine the mechanism by which the process works. One possibility is that this disruption lowers levels of insulin – another growth stimulus – which helps to increase longevity. The Ohio University research may lend support to that theory, as the mice that lived longer also had significantly lower insulin levels than the other mice under study, she said.

More research is needed to determine how the study findings in mice may be relevant to humans, particularly elderly individuals who undergo therapy to replace growth hormone lost during the natural aging process. As growth hormone plays many important, beneficial roles in the human body – including maintaining bone and tissue health – Coschigano says halting the body's production of growth hormone isn't the best approach. For example, researchers found that while the mice without the growth hormone receptor lived longer, they also were less fertile and had weaker bones.

"Growth hormone needs to be maintained at an intermediate level," said study co-author John Kopchick, Goll-Ohio Eminent Scholar and professor of molecular and cellular biology at EBI and the university's College of Osteopathic Medicine. "Not enough is not good, but too much is definitely not good."

Instead, the researchers are searching for genes regulated by growth hormone that might play a specific role in life span. Then, a therapy could be developed that would interrupt specific gene function, allowing the body to continue to reap the benefits of growth hormone without suffering the substance's sometimes negative effects.

The study was funded in part by the State of Ohio's Eminent Scholar Program and the Sensus Drug Development Corporation. Co-authors of the study are Kopchick, Linda Bellush, a former scientist with EBI and David Clemmons of the University of North Carolina at Chapel Hill.

The Edison Biotechnology Institute is a biomedical genetics institute at Ohio University and part of the Ohio Department of Development's Thomas Edison Program.


Story Source:

The above story is based on materials provided by Ohio University. Note: Materials may be edited for content and length.


Cite This Page:

Ohio University. "Growth Hormone May Shorten Life Span, Study Finds." ScienceDaily. ScienceDaily, 20 October 2000. <www.sciencedaily.com/releases/2000/10/001020092858.htm>.
Ohio University. (2000, October 20). Growth Hormone May Shorten Life Span, Study Finds. ScienceDaily. Retrieved October 25, 2014 from www.sciencedaily.com/releases/2000/10/001020092858.htm
Ohio University. "Growth Hormone May Shorten Life Span, Study Finds." ScienceDaily. www.sciencedaily.com/releases/2000/10/001020092858.htm (accessed October 25, 2014).

Share This



More Health & Medicine News

Saturday, October 25, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Texas Nurse Nina Pham Cured of Ebola

Texas Nurse Nina Pham Cured of Ebola

AFP (Oct. 25, 2014) — An American nurse who contracted Ebola while caring for a Liberian patient in Texas has been declared free of the virus and will leave the hospital. Duration: 01:01 Video provided by AFP
Powered by NewsLook.com
IKEA Desk Converts From Standing to Sitting With One Button

IKEA Desk Converts From Standing to Sitting With One Button

Buzz60 (Oct. 24, 2014) — IKEA is out with a new convertible desk that can convert from a sitting desk to a standing one with just the push of a button. Jen Markham explains. Video provided by Buzz60
Powered by NewsLook.com
Ebola Protective Suits Being Made in China

Ebola Protective Suits Being Made in China

AFP (Oct. 24, 2014) — A factory in China is busy making Ebola protective suits for healthcare workers and others fighting the spread of the virus. Duration: 00:38 Video provided by AFP
Powered by NewsLook.com
WHO: Millions of Ebola Vaccine Doses by 2015

WHO: Millions of Ebola Vaccine Doses by 2015

AP (Oct. 24, 2014) — The World Health Organization said on Friday that millions of doses of two experimental Ebola vaccines could be ready for use in 2015 and five more experimental vaccines would start being tested in March. (Oct. 24) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins